“vaccines” Archives

Entry Author Date Location
Genocea Climbs on Follow-Up Data for Herpes Vaccine 10/07/15 Boston
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard 09/10/15 Boston
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round 09/08/15 Boston
With $22M Shot of Venture, Sutro Spinout Aims For Better Vaccines 07/23/15 San Francisco
Biopharmaceutical Haiku, Round Two 07/06/15 Seattle
Selecta Takes Nanotech to Gene Therapy, Celiac With New Deals 05/13/15 Boston
Big Apple Biotech “Bootstraps” Forward at NewYorkBio Meeting 05/05/15 New York
Vaxxas Gets $20M Injection to Test Needle-Free Vaccines in Humans 02/09/15 Boston
More Green For Moderna as Merck Makes $50M Equity Grab, mRNA Deal 01/13/15 Boston
Moderna Forms Latest Venture, Valera, to Fight Infections With mRNA 01/08/15 Boston
Officials Say Fuji’s Purchase of Kalon Boosts Texas’s Biotech Profile 12/22/14 Texas
Accelerate LI’s Latest Startup Aims to Rewire Viruses With Software 12/16/14 New York
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech 10/30/14 Boston
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer 10/15/14 Boston
An Intriguing Program Takes on Tropical Diseases—But Not Ebola 09/10/14 National
West Coast Biotech Roundup: Amgen Layoffs, Avalanche, Venter & More 07/31/14 Seattle
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine 03/11/14 Boston
Seattle BioMed Nabs $10M NIAID Grant to Develop HIV Vaccines 03/10/14 Seattle
Vaccine Developer Genocea Prices IPO at $12 Per Share 02/05/14 Boston
Using Cutting-Edge Science and Technology Against an Age-Old Disease 01/24/14 Seattle
Madison Vaccines Closes $8M Series A Round for Prostate Treatment 01/13/14 Wisconsin
Vaccine Developer Genocea Files For IPO, Plans to Raise $75M 12/23/13 Boston
IDRI CEO Stewart Parker Steps Down, Erik Iverson Steps Up 12/19/13 Seattle
San Diego Life Sciences Roundup: Rempex, Pfenex, Halozyme & More 12/19/13 San Diego
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Gates Foundation Health Chief on Coaxing Pharma to Do Good (Part 2) 11/26/13 National
Gates Foundation Health Chief on Coaxing Pharma to Do Good 11/25/13 National
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
Genocea’s Herpes Vaccine Heads For Critical Proving Ground 09/12/13 Boston
Page 1 of 9 next page »